Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cebranopadol for painful diabetic peripheral neuropathy
NL-OMON40164Phase 2Active, not recruiting
- Sponsor
- Grünenthal GmbH
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cebranopadol in diabetic polyneuropathy (DPN) (4 arms), sponsored by Grünenthal GmbH. Started Sep 2013; status: active, not recruiting.
02
Drugs
cebranopadol
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on NL-OMON40164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40164.